[Biweekly CHOP-E chemotherapy for aggressive non-Hodgkin's lymphoma].
Hayashi
T
T
First Dept. of Internal Medicine, Sapporo Medical University.
Takahashi
T
T
Mihara
M
M
Shimizu
H
H
Tsukuda
H
H
Kobayashi
T
T
Adachi
M
M
Hinoda
Y
Y
Aoki
S
S
Mori
M
M
Tsujisaki
M
M
Imai
K
K
D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000008:administration & dosage; D011994:Recombinant Proteins; D012074:Remission Induction; D014750:Vincristine / Q000008:administration & dosage
D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone